We do not aim to diagnose, treat, cure or prevent any illness or disease
These medications work by mimicking the effects of GLP-1 in the body, leading to enhanced insulin secretion, reduced glucagon production, and increased satiety, thereby improving blood sugar control and promoting weight loss
News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
GLP-1RA is safe for use in children and adolescents over the age of 10 years, and some formulations have been approved for pediatric T2DM or obesity
We accept insurance and handle prior authorization on your behalf
Coordinating multiple injections requires practical planning